IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.611
AS - Asia 4.499
EU - Europa 4.207
SA - Sud America 1.248
Continente sconosciuto - Info sul continente non disponibili 304
AF - Africa 86
OC - Oceania 1
Totale 14.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.310
RU - Federazione Russa 2.392
SG - Singapore 1.782
CN - Cina 1.269
BR - Brasile 1.002
IT - Italia 653
HK - Hong Kong 549
SE - Svezia 526
VN - Vietnam 438
FR - Francia 213
BD - Bangladesh 126
CA - Canada 126
DE - Germania 116
GB - Regno Unito 101
AR - Argentina 90
IN - India 68
EC - Ecuador 49
MX - Messico 49
ID - Indonesia 40
FI - Finlandia 31
TR - Turchia 29
IQ - Iraq 28
CO - Colombia 27
JP - Giappone 27
PY - Paraguay 27
IE - Irlanda 26
PL - Polonia 24
NL - Olanda 21
ZA - Sudafrica 21
AT - Austria 20
CR - Costa Rica 20
ES - Italia 19
JM - Giamaica 19
UZ - Uzbekistan 19
PE - Perù 15
PK - Pakistan 15
LT - Lituania 14
HN - Honduras 13
UA - Ucraina 13
CL - Cile 12
MY - Malesia 12
PR - Porto Rico 12
SA - Arabia Saudita 12
VE - Venezuela 12
GT - Guatemala 11
MA - Marocco 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
IR - Iran 10
EG - Egitto 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
BB - Barbados 8
NI - Nicaragua 8
PH - Filippine 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
JO - Giordania 7
NP - Nepal 7
UY - Uruguay 7
KE - Kenya 6
AZ - Azerbaigian 5
ET - Etiopia 5
IL - Israele 5
OM - Oman 5
CZ - Repubblica Ceca 4
EU - Europa 4
KW - Kuwait 4
SC - Seychelles 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BH - Bahrain 3
DK - Danimarca 3
GP - Guadalupe 3
KZ - Kazakistan 3
LY - Libia 3
MD - Moldavia 3
AM - Armenia 2
BM - Bermuda 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
EE - Estonia 2
GY - Guiana 2
HT - Haiti 2
LK - Sri Lanka 2
MK - Macedonia 2
QA - Qatar 2
SN - Senegal 2
SR - Suriname 2
TH - Thailandia 2
VC - Saint Vincent e Grenadine 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BG - Bulgaria 1
BS - Bahamas 1
GA - Gabon 1
Totale 14.637
Salva come PNG Salva come JPEG
Città #
Dallas 722
Singapore 699
Ashburn 591
Moscow 555
Hong Kong 540
San Jose 471
Shanghai 293
Council Bluffs 233
Hefei 212
Milan 198
Princeton 194
Lawrence 191
Lauterbourg 181
Ho Chi Minh City 154
New York 127
Beijing 118
Hanoi 97
Santa Clara 85
São Paulo 85
Los Angeles 68
Phoenix 50
Rome 49
Miano 39
Orem 32
Da Nang 31
Brooklyn 30
Boardman 29
Brasília 28
Chicago 27
Atlanta 26
Nuremberg 26
Dublin 25
Belo Horizonte 24
Chennai 24
Haiphong 24
Helsinki 24
Montreal 24
Houston 23
Rio de Janeiro 23
North Bergen 21
London 20
Munich 20
Brescia 19
Guangzhou 19
Warsaw 19
Denver 18
Naples 18
Quito 18
Tashkent 18
Mexico City 17
Porto Alegre 16
Tokyo 16
Guayaquil 15
Johannesburg 15
Salvador 15
San José 15
Toronto 15
Washington 15
Biên Hòa 14
Boston 14
Frankfurt am Main 14
Hangzhou 14
The Dalles 14
Curitiba 12
Manchester 12
Mumbai 12
Philadelphia 12
San Francisco 12
Charlotte 11
Las Vegas 11
Bogotá 10
Changsha 10
Sorocaba 10
Stockholm 10
Ankara 9
Bologna 9
Buffalo 9
Campinas 9
Catania 9
Columbus 9
Fortaleza 9
Guarulhos 9
Kingston 9
Lima 9
Poplar 9
São Bernardo do Campo 9
Bari 8
Buenos Aires 8
Dhaka 8
Hải Dương 8
Istanbul 8
Kuala Lumpur 8
Managua 8
Recife 8
Uberlândia 8
Vienna 8
Amsterdam 7
Bridgetown 7
Calgary 7
Detroit 7
Totale 7.109
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 232
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 161
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 159
[New therapeutic options for the treatment of tricuspid regurgitation] 151
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 147
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 141
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 136
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 128
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 127
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 120
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 119
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 117
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 113
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 113
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 113
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 113
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 109
Diabetes and mortality in patients with COVID-19: Are we missing the link? 109
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 108
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 106
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 105
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 105
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 105
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 105
A new tool for the forgotten valve: a score to predict the risk of surgery 104
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 102
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 100
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 100
[40 Years of coronary angioplasty: success comes from skills and determination!] 100
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 98
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 98
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 97
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 97
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 95
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 91
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 91
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 88
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 88
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 87
Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry 86
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 86
Advances in percutaneous interventional therapies: The tricuspid valve 86
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 86
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 84
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 84
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 83
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 83
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 82
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 82
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 81
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 80
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 79
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 78
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 78
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 78
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 78
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 77
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 77
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 77
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 76
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 76
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 75
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 74
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 74
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 74
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 74
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 72
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 72
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 71
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 70
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 70
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 69
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 69
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 69
Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study 69
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 68
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 68
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 68
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 68
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 67
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 67
Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings 67
Subclinical Leaflet Thrombosis After Transcatheter Mitral Valve-in-Ring Implantation 67
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 67
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 66
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 66
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 66
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 66
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 66
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 65
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 65
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 65
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 65
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 64
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 64
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study 64
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? 64
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 64
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 63
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 63
Totale 8.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202294 0 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/20252.582 386 23 16 59 63 209 361 186 452 293 257 277
2025/20268.381 503 786 919 1.288 581 188 680 491 2.147 356 224 218
2026/20272.225 309 563 471 882 0 0 0 0 0 0 0 0
Totale 14.956